Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
about
Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye diseaseSex differences in Sjögren's syndrome: a comprehensive review of immune mechanismsCornea and ocular surface disease: application of cutting-edge optometric researchEstablishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndromePax6 downregulation mediates abnormal lineage commitment of the ocular surface epithelium in aqueous-deficient dry eye diseaseInterleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesCritical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.Targeting IL-1 in Sjögren's syndrome.Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions.Macrophages: important players in primary Sjögren's syndrome?[Testosterone reduces the expression of keratinization-promoting genes in murine Meibomian glands].Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction.
P2860
Q24563932-36F0A743-7C5A-4785-AA66-856E66A15ECDQ26780324-C9028AC5-3E89-42D3-8EBB-3058BFA9911EQ27010492-5A333871-FCB6-4C36-82FD-2F27548CA454Q34473772-AB9FC649-AE09-43F5-AA65-26293F8CE591Q35021717-DF05076F-6CA1-432D-905B-F1285A6925B1Q35133812-AD2E2FF6-14CC-40E1-841A-EF6A99637F2CQ36204121-473273B0-0BDC-46B8-942F-44E31A82F84EQ37195776-96BBBE9D-C6CB-45AA-A3C4-DCAD8A3F8ED3Q38074174-3F436E34-8C2F-4D40-8CF5-54600DED2B69Q38076460-81D01396-1727-4EC7-A5AA-F64AE2D4AD44Q38197286-D2FF59A2-E180-4EC7-841B-9431F1B55491Q38493622-13BF9B3C-5E63-4676-BC1B-A4C427C2822CQ39173291-C65FB925-34F9-405F-9A23-0E462DDD3782Q41677137-361D8BD7-5497-43DD-87D2-E89ABB78EFB4Q48277140-728679DF-EFDB-4949-AA89-C112FEFA3D3D
P2860
Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@en
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@nl
type
label
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@en
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@nl
prefLabel
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@en
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@nl
P2093
P2860
P1476
Interleukin-1 receptor mediate ...... aplasia in Sjögren's syndrome.
@en
P2093
Ahmad F Bahrami
Feeling Y T Chen
Lisa B Noble
Mahesh Yadav
Marianne Gallup
Nancy A McNamara
Stanislav Lazarev
Ying-Ting Chen
P2860
P2888
P304
P356
10.1038/LABINVEST.2011.189
P577
2012-01-09T00:00:00Z
P5875
P6179
1053490397